Study rationale and design of a study of EMPAgliflozin's effects in patients with type 2 diabetes mellitus and Coronary ARtery disease: the EMPA-CARD randomized controlled trial.

Sepehr GohariTara ReshadmaneshHadi KhodabandehlooMojtaba FathiHassan AhangarShahram Arsang-JangFaramarz Ismail-BeigiSamin GhanbariMohsen DadashiMuhammad Javad MuhammadiSheida GohariSaeid Ghaffari

Published in: BMC cardiovascular disorders (2021)

Iranian Registry of Clinical Trials. www.IRCT.ir , Identifier: IRCT20190412043247N2. Registration Date: 6/13/2020. Registration timing: prospective.

Keyphrases

randomized controlled trial
coronary artery disease
clinical trial
study protocol
percutaneous coronary intervention
cardiovascular events
coronary artery bypass grafting
systematic review
acute coronary syndrome
phase ii
ejection fraction
meta analyses